Tango Therapeutics, Inc. (TNGX)
24.52
+0.64
(+2.68%)
USD |
NASDAQ |
Aug 24, 16:00
24.52
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Total Liabilities (Quarterly) : 49.35M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.35M |
| March 31, 2026 | 44.29M |
| December 31, 2025 | 63.83M |
| September 30, 2025 | 50.10M |
| June 30, 2025 | 102.94M |
| March 31, 2025 | 107.55M |
| December 31, 2024 | 129.42M |
| September 30, 2024 | 123.24M |
| June 30, 2024 | 133.78M |
| March 31, 2024 | 141.77M |
| December 31, 2023 | 163.43M |
| September 30, 2023 | 151.59M |
| June 30, 2023 | 166.38M |
| Date | Value |
|---|---|
| March 31, 2023 | 176.51M |
| December 31, 2022 | 202.03M |
| September 30, 2022 | 191.08M |
| June 30, 2022 | 149.70M |
| March 31, 2022 | 151.17M |
| December 31, 2021 | 155.41M |
| September 30, 2021 | 164.72M |
| June 30, 2021 | 6.192M |
| March 31, 2021 | 6.138M |
| December 31, 2020 | 168.65M |
| September 30, 2020 | 5.951M |
| June 30, 2020 | 0.039M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.717B |
| Erasca, Inc. | 73.18M |
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.074B |
| Shareholders Equity (Quarterly) | 1.025B |
| Debt to Equity Ratio | 0.0312 |
| Current Ratio | 50.82 |
| Net Debt Paydown Yield | 0.02% |